Is Ambrx Biopharma Inc. (AMAM) Stock Outpacing Its Medical Peers This Year? [Yahoo! Finance]
Ambrx Biopharma, Inc. (AMAM)
Company Research
Source: Yahoo! Finance
Has Ambrx Biopharma Inc. (AMAM) been one of those stocks this year? Let's take a closer look at the stock's year-to-date performance to find out. Ambrx Biopharma Inc. is one of 1069 individual stocks in the Medical sector. Collectively, these companies sit at #4 in the Zacks Sector Rank. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst. The Zacks Rank is a proven model that highlights a variety of stocks with the right characteristics to outperform the market over the next one to three months. The system emphasizes earnings estimate revisions and favors companies with improving earnings outlooks. Ambrx Biopharma Inc. is currently sporting a Zacks Rank of #2 (Buy). Within the past quarter, the Zacks Consensus Estimate for AMAM's full-year earnings has moved 1% higher. This signals that analyst sentiment is improving and the stock's earnings outlo
Show less
Read more
Impact Snapshot
Event Time:
AMAM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AMAM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AMAM alerts
High impacting Ambrx Biopharma, Inc. news events
Weekly update
A roundup of the hottest topics
AMAM
News
- Ambrx Shareholders Approve Acquisition by Johnson & JohnsonGlobeNewswire
- SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates AMAM, JNPR, INBX, RYZBPR Newswire
- AMBRX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Ambrx Biopharma, Inc. - AMAMBusiness Wire
- SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates AMAM, HARP, JNPR, TGANGlobeNewswire
- Lifshitz Law PLLC Announces Investigations of AMAM, HARP, AXNX, and FGHAccesswire
AMAM
Sec Filings
- 3/8/24 - Form S-8
- 3/8/24 - Form S-8
- 3/8/24 - Form S-8
- AMAM's page on the SEC website